Experimental research has examined Semax in animal models of neurological injury as well as in human studies involving cognitive function and neurological conditions. Research has also investigated effects involving neurotrophic factors such as brain-derived neurotrophic factor (BDNF) and signaling pathways associated with neuronal and neuroimmune responses. Findings should be interpreted according to the study population, experimental model, formulation, and specific endpoints measured.